Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice

Intermediates and final products of protein aggregation play crucial role in the development of degenerative changes in a number of neurological diseases. Pathological protein aggregation is currently regarded as one of the most promising therapeutic targets for treatment of these diseases. Transgen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachurin, Sergey O., Shelkovnikova, Tatyana A., Ustyugov, Alexey A., Peters, Owen, Khritankova, Ina, Afanasieva, Marina A., Tarasova, Tatyana V., Alentov, Igor I., Buchman, Vladimir L., Ninkina, Natalia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351599/
https://www.ncbi.nlm.nih.gov/pubmed/22179976
http://dx.doi.org/10.1007/s12640-011-9299-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351599/
https://www.ncbi.nlm.nih.gov/pubmed/22179976
http://dx.doi.org/10.1007/s12640-011-9299-y

Ejemplares similares